Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Van K. Morris, Erin B. Kennedy, Nancy N. Baxter, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 3, pp. 678-700
Open Access | Times Cited: 312

Showing 1-25 of 312 citing articles:

Colorectal cancer statistics, 2023
Rebecca L. Siegel, Nikita Sandeep Wagle, Andrea Cercek, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 3, pp. 233-254
Open Access | Times Cited: 2531
Therapeutic landscape and future direction of metastatic colorectal cancer
Hideaki Bando, Atsushi Ohtsu, Takayuki Yoshino
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 5, pp. 306-322
Closed Access | Times Cited: 81
Stage IV Colorectal Cancer Management and Treatment
Oscar Hernandez Dominguez, Sümeyye Yılmaz, Scott R. Steele
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2072-2072
Open Access | Times Cited: 67
Colorectal cancer
Cathy Eng, Takayuki Yoshino, Érika Ruiz-García, et al.
The Lancet (2024) Vol. 404, Iss. 10449, pp. 294-310
Closed Access | Times Cited: 44
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer
Kohei Shitara, Kei Muro, Jun Watanabe, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 730-739
Open Access | Times Cited: 32
GPT-4 for Information Retrieval and Comparison of Medical Oncology Guidelines
Dyke Ferber, Isabella C. Wiest, Georg Wölflein, et al.
NEJM AI (2024) Vol. 1, Iss. 6
Closed Access | Times Cited: 25
Advancements in combining targeted therapy and immunotherapy for colorectal cancer
Manisha Singh, Van K. Morris, Irfan Bandey, et al.
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 598-609
Closed Access | Times Cited: 21
Management of Locally Advanced Rectal Cancer: ASCO Guideline
Aaron J. Scott, Erin B. Kennedy, Jordan Berlin, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 28, pp. 3355-3375
Closed Access | Times Cited: 21
Colorectal cancer: Recent advances in management and treatment
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 9, pp. 1136-1156
Open Access | Times Cited: 15
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Thierry André, Elena Élez, Heinz‐Josef Lenz, et al.
The Lancet (2025)
Closed Access | Times Cited: 5
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
Scott Kopetz, Takayuki Yoshino, Eric Van Cutsem, et al.
Nature Medicine (2025)
Open Access | Times Cited: 2
Liquid Biopsy and Challenge of Assay Heterogeneity for Minimal Residual Disease Assessment in Colon Cancer Treatment
Giovanni Crisafulli
Genes (2025) Vol. 16, Iss. 1, pp. 71-71
Open Access | Times Cited: 1
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
Carmine Pinto, Sara Lonardi, Evaristo Maiello, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases
Anita K. Bakrania, Narottam Joshi, Xun Zhao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106706-106706
Open Access | Times Cited: 38
Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE
Ajith K. Siriwardena, Alejandro Serrablo, Åsmund Avdem Fretland, et al.
British journal of surgery (2023) Vol. 110, Iss. 9, pp. 1161-1170
Open Access | Times Cited: 29
Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases
Qiang Wang, Peng Liu, Yingfei Wen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer
Ké Li, Wei Liu, Hang Yu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 4
Open Access | Times Cited: 11
Recent advances and remaining challenges in lung cancer therapy
Tasha Barr, Shoubao Ma, Zhixin Li, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 5, pp. 533-546
Open Access | Times Cited: 10
Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring
Xiang-Yuan Tao, Qianqian Li, Yong Zeng
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness
Takayuki Yoshino, Naushin Hooda, Diana Younan, et al.
European Journal of Cancer (2024) Vol. 202, pp. 113975-113975
Closed Access | Times Cited: 9
Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients
Izabela Ciepiela, Magdalena Szczepaniak, Przemysław Ciepiela, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer
Bo Zhang, Yi Pan, Zhe Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Clinico‐Pathological Significance of Tumor Infiltrating Immune Cells in Oral Squamous Cell Carcinoma—Hope or Hype?
Rajkumar Kottayasamy Seenivasagam, Ashok Singh, Vinay N. Gowda, et al.
Head & Neck (2025)
Open Access | Times Cited: 1
A mathematical model with fractional-order dynamics for the combined treatment of metastatic colorectal cancer
David Amilo, Khadijeh Sadri, Bilgen Kaymakamzade, et al.
Communications in Nonlinear Science and Numerical Simulation (2023) Vol. 130, pp. 107756-107756
Closed Access | Times Cited: 21
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials
Daniele Rossini, Alessandra Boccaccino, Martina Carullo, et al.
European Journal of Cancer (2023) Vol. 184, pp. 106-116
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top